Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (71)

« Back to Publications

Age differences in immunity to human seasonal coronaviruses and the immunogenicity of ChAdOx1 nCoV-19 (AZD1222)

Belij-Rammerstorfer S. et al, (2025), eBioMedicine, 118, 105847 - 105847

Pf8: an open dataset of Plasmodium falciparum genome variation in 33,325 worldwide samples

Abdel Hamid MM. et al, (2025), Wellcome Open Research, 10, 325 - 325

Establishing laboratory reference ranges for haematological and biochemical blood parameters in adults and children in Kilifi, Kenya

Downs LO. et al, (2025), Wellcome Open Research, 10, 312 - 312

A pragmatic randomized controlled trial of standard care versus corticosteroids plus standard care for treatment of pneumonia in adults admitted to Kenyan hospitals (SONIA)

Lucinde R. et al, (2025), Wellcome Open Research, 7, 269 - 269

Development of an oral regimen of unithiol for the treatment of snakebite envenoming: a phase 1 open-label dose-escalation safety trial and pharmacokinetic analysis in healthy Kenyan adults.

Abouyannis M. et al, (2025), EBioMedicine, 113

Pf8: an open dataset of Plasmodium falciparum genome variation in 33,325 worldwide samples.

Malaria Genomic Epidemiology Network (MalariaGEN) . et al, (2025), Wellcome open research, 10

Establishing laboratory reference ranges for adults and children in Kilifi, Kenya

Downs LO. et al, (2024)

Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial

Schilling WHK. et al, (2024), PLOS Medicine, 21, e1004428 - e1004428

SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART)

Maitland K. et al, (2024)

SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART)

Maitland K. et al, (2024), Wellcome Open Research, 8, 484 - 484

Nutritional supplementation in children with severe pneumonia in Uganda and Kenya (COAST-Nutrition): a phase 2 randomised controlled trial.

Kiguli S. et al, (2024), EClinicalMedicine, 72

Safety and immunogenicity of varied doses of R21/Matrix-M™ vaccine at three years follow-up: A phase 1b age de-escalation, dose-escalation trial in adults, children, and infants in Kilifi-Kenya

Sang S. et al, (2024)

A Phase I trial of Non-invasive Ventilation and seizure prophylaxis with levetiracetam In Children with Cerebral Malaria Trial (NOVICE-M Trial)

Maitland K. et al, (2024), Wellcome Open Research, 9, 281 - 281

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial

Datoo MS. et al, (2024), The Lancet, 403, 533 - 544

SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART)

Maitland K. et al, (2024)

Load More

1
2
3
4
5